Skip to main content
. 2018 Dec 13;10(12):534. doi: 10.3390/toxins10120534

Figure 2.

Figure 2

Schematic representation of how small molecule inhibitors may be used in combination with conventional antivenom or biosynthetic oligoclonal antivenom (BOA) against snakebite to strategically neutralize key toxins that are poorly neutralized by the antivenom or BOA.